Prospectus Supplement No. 2, dated September 8, 2000, Rule 424(c) to Prospectus, dated June 30, 2000. File No. 333-33242 ALLIANCE PHARMACEUTICAL CORP. COMMON STOCK ------------ This prospectus supplement relates to the public offering of shares of our common stock by the selling shareholders named in the prospectus referenced above. The Selling Shareholder Table in the prospectus referenced above is hereby amended. Portions of the warrant to purchase 760,000 shares of common stock, dated June 10, 1999, owned by Roth Capital Partners, one of the selling shareholders, has been transferred. The warrant is now owned as follows: NUMBER OF SHARES OF COMMON STOCK NUMBER OF SHARES OF NUMBER OF SHARES OF COMMON BENEFICIALLY COMMON STOCK TO BE STOCK BENEFICIALLY OWNED ACQUISITION OF COMMON OWNED BEFORE OFFERED BY THIS AFTER THE OFFERING(2) STOCK OFFERED BY THIS SELLING SHAREHOLDERS OFFERING(1) PROSPECTUS PROSPECTUS NUMBER PERCENTAGE Roth Capital Partners 639,273 639,273 -0- -0- Represents 639,273 shares of common stock underlying a warrant, dated June 10, 1999, exercisable at $3.675 per share. Jan A. Dekker 332,883 173,333 159,550 * Represents 117,911 shares of common stock underlying a warrant, dated June 10, 1999, exercisable at $3.675 per share and 55,422 shares of common stock underlying a warrant, dated July 2, 1999, exercisable at $2.95 per share. Gregory Huston 19,000 2,000 17,000 * Represents 2,000 shares of common stock underlying a warrant, dated June 10, 1999, exercisable at $3.675 per share Barry Pearl 2,116 816 1,300 * Represents 816 shares of common stock underlying a warrant, dated June 10, 1999, exercisable at $3.675 per share * Indicates ownership of less than 1% of outstanding shares (1) Includes the shares of common stock underlying the warrants, 5% subordinated convertible debentures, 6% subordinated convertible notes and Series D Preferred Stock being offered by this prospectus. (2) based on 50,384,120 shares of Alliance's common stock outstanding and which number assumes the sale of all the shares of common stock registered under this prospectus to persons who are not affiliates of the selling shareholders.